Cargando…

Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons

Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokota, Mutsumi, Kakuta, Soichiro, Shiga, Takahiro, Ishikawa, Kei-ichi, Okano, Hideyuki, Hattori, Nobutaka, Akamatsu, Wado, Koike, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986497/
https://www.ncbi.nlm.nih.gov/pubmed/33757554
http://dx.doi.org/10.1186/s13041-021-00771-0
_version_ 1783668456105705472
author Yokota, Mutsumi
Kakuta, Soichiro
Shiga, Takahiro
Ishikawa, Kei-ichi
Okano, Hideyuki
Hattori, Nobutaka
Akamatsu, Wado
Koike, Masato
author_facet Yokota, Mutsumi
Kakuta, Soichiro
Shiga, Takahiro
Ishikawa, Kei-ichi
Okano, Hideyuki
Hattori, Nobutaka
Akamatsu, Wado
Koike, Masato
author_sort Yokota, Mutsumi
collection PubMed
description Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PRKN mutations is characterized by the preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta, which has been suggested to result from the accumulation of damaged mitochondria. However, ultrastructural changes of mitochondria specifically in dopaminergic neurons derived from iPSC have rarely been analyzed. The main reason for this would be that the dopaminergic neurons cannot be distinguished directly among a mixture of iPSC-derived differentiated cells under electron microscopy. To selectively label dopaminergic neurons and analyze mitochondrial morphology at the ultrastructural level, we generated control and PRKN-mutated patient tyrosine hydroxylase reporter (TH-GFP) induced pluripotent stem cell (iPSC) lines. Correlative light-electron microscopy analysis and live cell imaging of GFP-expressing dopaminergic neurons indicated that iPSC-derived dopaminergic neurons had smaller and less functional mitochondria than those in non-dopaminergic neurons. Furthermore, the formation of spheroid-shaped mitochondria, which was induced in control dopaminergic neurons by a mitochondrial uncoupler, was inhibited in the PRKN-mutated dopaminergic neurons. These results indicate that our established TH-GFP iPSC lines are useful for characterizing mitochondrial morphology, such as spheroid-shaped mitochondria, in dopaminergic neurons among a mixture of various cell types. Our in vitro model would provide insights into the vulnerability of dopaminergic neurons and the processes leading to the preferential loss of dopaminergic neurons in patients with PRKN mutations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-021-00771-0.
format Online
Article
Text
id pubmed-7986497
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79864972021-03-24 Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons Yokota, Mutsumi Kakuta, Soichiro Shiga, Takahiro Ishikawa, Kei-ichi Okano, Hideyuki Hattori, Nobutaka Akamatsu, Wado Koike, Masato Mol Brain Methodology Mitochondrial structural changes are associated with the regulation of mitochondrial function, apoptosis, and neurodegenerative diseases. PRKN is known to be involved with various mechanisms of mitochondrial quality control including mitochondrial structural changes. Parkinson’s disease (PD) with PRKN mutations is characterized by the preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta, which has been suggested to result from the accumulation of damaged mitochondria. However, ultrastructural changes of mitochondria specifically in dopaminergic neurons derived from iPSC have rarely been analyzed. The main reason for this would be that the dopaminergic neurons cannot be distinguished directly among a mixture of iPSC-derived differentiated cells under electron microscopy. To selectively label dopaminergic neurons and analyze mitochondrial morphology at the ultrastructural level, we generated control and PRKN-mutated patient tyrosine hydroxylase reporter (TH-GFP) induced pluripotent stem cell (iPSC) lines. Correlative light-electron microscopy analysis and live cell imaging of GFP-expressing dopaminergic neurons indicated that iPSC-derived dopaminergic neurons had smaller and less functional mitochondria than those in non-dopaminergic neurons. Furthermore, the formation of spheroid-shaped mitochondria, which was induced in control dopaminergic neurons by a mitochondrial uncoupler, was inhibited in the PRKN-mutated dopaminergic neurons. These results indicate that our established TH-GFP iPSC lines are useful for characterizing mitochondrial morphology, such as spheroid-shaped mitochondria, in dopaminergic neurons among a mixture of various cell types. Our in vitro model would provide insights into the vulnerability of dopaminergic neurons and the processes leading to the preferential loss of dopaminergic neurons in patients with PRKN mutations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-021-00771-0. BioMed Central 2021-03-23 /pmc/articles/PMC7986497/ /pubmed/33757554 http://dx.doi.org/10.1186/s13041-021-00771-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Methodology
Yokota, Mutsumi
Kakuta, Soichiro
Shiga, Takahiro
Ishikawa, Kei-ichi
Okano, Hideyuki
Hattori, Nobutaka
Akamatsu, Wado
Koike, Masato
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title_full Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title_fullStr Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title_full_unstemmed Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title_short Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
title_sort establishment of an in vitro model for analyzing mitochondrial ultrastructure in prkn-mutated patient ipsc-derived dopaminergic neurons
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986497/
https://www.ncbi.nlm.nih.gov/pubmed/33757554
http://dx.doi.org/10.1186/s13041-021-00771-0
work_keys_str_mv AT yokotamutsumi establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT kakutasoichiro establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT shigatakahiro establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT ishikawakeiichi establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT okanohideyuki establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT hattorinobutaka establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT akamatsuwado establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons
AT koikemasato establishmentofaninvitromodelforanalyzingmitochondrialultrastructureinprknmutatedpatientipscderiveddopaminergicneurons